North America Colorectal Cancer Diagnostics Market Trends, Size, Segment and Growth by Forecast to 2030

North America Colorectal Cancer Diagnostics Market Outlook (2023–2028)

The North American colorectal cancer diagnostics market was valued at US$ 4,315.86 million in 2023 and is projected to reach US$ 6,621.26 million by 2028, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period.

📚𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 – https://www.businessmarketinsights.com/sample/BMIRE00028834

Key Market Driver: Product Launches and Technological Advancements

The growth of the colorectal cancer diagnostics market in North America is largely driven by the continuous introduction of innovative products and diagnostic technologies. Leading industry players are developing a broad range of diagnostic tools aimed at reducing the burden of colorectal cancer and associated conditions such as colon polyps, Crohn’s disease, colitis, and irritable bowel syndrome.

Notably, in July 2022, US Digestive Health (USDH)—a prominent network of gastrointestinal (GI) practices—introduced AI-assisted colonoscopy screenings through the largest national installation of Genious Intelligent GI endoscopy modules. These advanced systems aid in the real-time detection of difficult-to-identify and potentially cancerous polyps, enhancing early diagnosis and treatment across southeastern, southwestern, and central Pennsylvania.

In another significant development, Olympus Corporation launched the ENDO-AID platform in September 2020. This AI-powered diagnostic tool includes the ENDO-AID CADe application, a computer-aided detection system designed to identify abnormalities in the colon. When integrated with Olympus’s EVIS X1 endoscopy system, ENDO-AID allows for real-time visualization and detection of suspicious lesions, significantly improving diagnostic accuracy.

These ongoing innovations and frequent product launches are pivotal in propelling the growth of the colorectal cancer diagnostics market across North America.

North America Colorectal Cancer Diagnostics Market Overview

The North America colorectal cancer diagnostics market comprises the US, Canada, and Mexico. In the US, colorectal cancer (CRC) is the third most commonly diagnosed cancer among both men and women. In 2023, an estimated 153,020 new CRC cases were reported, including 106,970 colon and 46,050 rectal cancer cases. While the disease primarily affects older adults, incidence rates are rising among younger populations. The lifetime risk of developing CRC is approximately 1 in 22 for men and 1 in 24 for women.

Mortality from CRC remains a major concern, with around 52,550 deaths projected in 2023. However, advances in diagnostics, early screening, and treatment have contributed to declining mortality rates over the past two decades. The American Cancer Society reports a five-year survival rate of 91% for localized colon cancer and 90% for localized rectal cancer.

Screening remains a key preventive measure. In 2021, the US Preventive Services Task Force updated its guidelines to recommend regular CRC screening starting at age 45, down from 50. High-sensitivity stool-based tests and visual exams are widely used depending on patient preferences and availability.

The region benefits from robust research support and advocacy. The Colorectal Cancer Alliance, the largest nonprofit in the field, continues to invest in research, including a $1.1 million funding boost in 2020. Additionally, over 600,000 surgeries are performed annually in the US to treat colon-related diseases, reflecting a high demand for diagnostic solutions.

Given these factors, the North America colorectal cancer diagnostics market is poised for significant growth during the forecast period.

North America Colorectal Cancer Diagnostics Strategic Insights

Strategic insights for the North America Colorectal Cancer Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Colorectal Cancer Diagnostics Report Scope

North America Colorectal Cancer Diagnostics Regional Insights

The geographic scope of the North America Colorectal Cancer Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

 North America Colorectal Cancer Diagnostics Market Segmentation

The North America colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the North America colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the North America colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gFOBT), and stool DNA test.

Based on end user, the North America colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the North America colorectal cancer diagnostics market.

Based on country, the North America colorectal cancer diagnostics market is segmented into the US, Canada, and Mexico. In 2023, the US accounted for the largest share of the North America colorectal cancer diagnostics market.

Medtronic Plc; Illumina Inc; Clinical Genomics Technologies Pty Ltd; EDP Biotech Corp; Epigenomics AG; F. Hoffmann-La Roche Ltd; Quest Diagnostics Inc; Siemens Healthineers AG; Bruker Corp; and Eiken Chemical Co., Ltd. are among the leading companies operating in the North America colorectal cancer diagnostics market.

Can you see this our reports –

North America Gas Engine Market – https://postyourarticle.com/north-america-gas-engine-market-trends-size-segment-and-growth-by-forecast-to-2030/

North America Medical Laser Systems Market – https://postyourarticle.com/north-america-medical-laser-systems-markettrends-size-segment-and-growth-by-forecast-to-2030-2/

North America Medical Packaging Market – https://postyourarticle.com/north-america-medical-packaging-market-trends-size-segment-and-growth-by-forecast-to-2030-3/

North America Western Blotting Market – https://postyourarticle.com/north-america-western-blotting-market-trends-size-segment-and-growth-by-forecast-to-2030-2/

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights